Translational PD Studies in Early Stage CNS Drug Development
24th October 2013 at Academy of Medical Sciences
Each year members and non-members are invited to an annual conference focused on a chosen topical issue. This year’s event was well attended and has been praised by delegates for the high quality of information and informative presentations. A collection of specialist presentations were delivered by our highly acclaimed speakers, Prof. Praveen Anand, Dr. John Connell, Prof. Derk-Jan Dijk, Prof. Keith Wesnes and Prof. Steve Williams. Delegates also took part in a lively debate, and had opportunities to network and participate in shaping the future of the AHPPI. Please view our presentation pdfs below.
The Role Of Contemporary MR Imaging Techniques in Early CNS Drug Development
Prof. Steve Williams, King’s College London
Effects of Hypnotics and Wake Promoting Compounds of the Sleep and Wake EEG
Prof. Derk-Jan Dijk, University of Surrey
Meeting Translational Needs for Novel Pain Drug Development
Prof. Praveen Anand, Imperial College London
The Role of Human Models of Disease State in Accelerating Early Clinical Development for CNS Active Compounds
Dr. John Connell, Icon Development Solutions
Translational Medicine for CNS Compounds is Alive and Well in Phase I: A Review of 30 Years’ Experience
Prof. Keith Wesnes, Bracket Global
We are pleased to be able to share with you the overwhelmingly positive feedback and comments collected from this years delegates. The main strengths were noted as “Very interesting. Nice variation in the topics. Easy to reach venue” and “Excellent speakers”.
To read more, click here.
Event sponsored by: